about
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery.An aptamer-targeting photoresponsive drug delivery system using "off-on" graphene oxide wrapped mesoporous silica nanoparticlesQuantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue modelNovel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 ExpressionOptical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies.Biomineralization-Inspired Synthesis of Copper Sulfide-Ferritin Nanocages as Cancer Theranostics.Dual-enhanced photothermal conversion properties of reduced graphene oxide-coated gold superparticles for light-triggered acoustic and thermal theranostics.Triphase interface synthesis of plasmonic gold bellflowers as near-infrared light mediated acoustic and thermal theranostics.Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.In vivo quantitative photoacoustic microscopy of gold nanostar kinetics in mouse organs.Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on CuS nanoparticlesPreclinical lymphatic imaging.Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressionsDynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS.Delayed postconditioning protects against focal ischemic brain injury in rats.Phage display peptide probes for imaging early response to bevacizumab treatment.Phage display-derived peptides for osteosarcoma imagingDesign considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homingPET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.Glucose oxidase-catalyzed growth of gold nanoparticles enables quantitative detection of attomolar cancer biomarkers.High-affinity peptide against MT1-MMP for in vivo tumor imagingTumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticles.Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculatureThe genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal developmentA symmetrical fluorous dendron-cyanine dye-conjugated bimodal nanoprobe for quantitative 19F MRI and NIR fluorescence bioimaging.Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostarsChelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene.Dual-factor triggered fluorogenic nanoprobe for ultrahigh contrast and subdiffraction fluorescence imaging.PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.[(18)F]DPA-714 PET imaging of AMD3100 treatment in a mouse model of stroke.(18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy.
P50
Q26771417-2505840C-D24E-4C67-93B9-07621DBA6017Q27300748-3831787F-4805-4D37-8F72-A6BDFC39A26FQ28468532-B7C4425F-9D43-47D1-81A3-55D06DDF29FFQ28729872-B27E3F43-B110-4B0B-A742-421B572B1DA5Q28817842-9A3C47D4-5E66-4415-8347-E579D901FB7AQ28829149-78BE923A-5EFD-410B-B36B-16FEE9E1CA71Q30365229-01F31E2C-A5B2-4DE4-997D-3652E26A92A8Q30365488-1EB0E4CF-C054-49B3-8E02-0B6D8B43A6E7Q30366084-EAE930C8-1EC6-4015-8C94-C38683DFE161Q30411585-4A6CFA13-9EB3-423C-B260-E98BF56C8E88Q30414688-F7742AA2-684C-4B3E-81E9-AA9614F99994Q30432833-985839F2-AFE5-455F-BD47-8E78A0C91DCAQ30444146-5F09CB4A-D0E4-4A5D-9AEF-2EF139DF59A3Q30465292-38B6E3E2-A5EB-4F02-AD10-E0A33B90EDC0Q30501344-496E89EE-FA6A-460B-945D-36865E1F1EA5Q30524330-61F61452-0E88-4C72-B096-85BF68E25187Q30540289-C97D7760-3927-4239-A8EF-532C6BC8D664Q30573504-680332F5-7FBB-424F-AD01-2C2B175EA7F8Q30856771-D6B99448-B082-41D6-A946-AFD0E55B6977Q33391388-E1F5F9CB-2574-445E-A871-737ED1812FC9Q33541076-7DAD2533-CE85-4522-8140-8E5AF2AC7842Q33613448-63A8DD1D-AF1C-40C8-8CEB-5C5AF944D9E7Q33716075-F851D46A-8991-45FC-B484-0CF727FBA10DQ33748021-2273D221-81B8-48E6-851B-8D6FE5D53F5EQ33767100-5B6A1A26-7849-456C-8DD4-67738069CD07Q33791805-DBDF021C-5636-4CFA-9E71-151DB1BA6DD0Q33812205-C96D20E3-DBB8-4125-8AC3-03EB69580A2BQ33824812-E04DA4FA-5AEB-4CA0-966E-AAF574DE6D98Q33832487-C9B0F1E8-0F92-4CCC-A339-C557572EFD5CQ33881257-6DA06539-30A2-4A2E-97A1-DA3DAD250FC8Q34052606-1FBAB6B3-58D3-4DA4-A246-FD06975CB7E0Q34069167-FE240330-A5ED-4D68-8E0C-C5C3B30A5E34Q34104295-7F3C5E9D-A27B-47AA-8047-689070D42701Q34194326-A6EF2D6B-5E5A-41D8-B085-A72ABAC2189EQ34205394-B21C8640-681B-403C-8890-9819979F251FQ34270431-0E5F897E-6622-442B-8765-7786B3E2420FQ34284396-ADCF832E-FFF3-41B8-8822-2471DEFA0A8FQ34293578-716BE31D-028E-44EB-BCE8-C0AB1DB8D31CQ34407276-36088DD3-FAFE-419E-9B04-33D72B2C4734Q34430803-B7586D56-825A-4B32-9E7D-01C58E49771C
P50
name
Gang Niu
@ast
Gang Niu
@en
Gang Niu
@nl
type
label
Gang Niu
@ast
Gang Niu
@en
Gang Niu
@nl
prefLabel
Gang Niu
@ast
Gang Niu
@en
Gang Niu
@nl